We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Stakeholders: FCC Decision Will Have Impact On Patient Monitors

Stakeholders: FCC Decision Will Have Impact On Patient Monitors

August 14, 2015

A recent ruling from the Federal Communications Commission could affect the operation of patient monitoring equipment in hospitals.

In early August, the FCC adopted rules that will permit unlicensed television white space devices — including Wi-Fi and Bluetooth technologies — and wireless microphones to operate on Channel 37 in the 600 MHz band, as long as they don’t interfere with licensed wireless medical telemetry systems.

The vote comes as the commission prepares for a scheduled March 29, 2016, incentive auction to make available high-quality, low-band spectrum for mobile broadband.

Through these auctions, television broadcasters will go off the air, and share their spectrum or move channels in exchange for part of the proceeds from wireless providers seeking additional broadband, according to the FCC’s website.

Many healthcare stakeholders have expressed concern that adequate protections would not be put in place. Commissioner Ajit Pai said the FCC assumed that hospitals with WMTS devices are no more than three stories tall. That is not the case with the majority of such facilities.

“The WMTS community is not alone in its worry,” he writes. “A bipartisan group of nearly 20 members of the U.S. Senate and House of Representatives recently weighed in on this issue. They noted that the record includes the results of real-world testing at three different hospitals demonstrating that interference to WMTS systems will be caused by a TVWS [TV white space] device operating at the power levels and distances proposed by the commission.”

To guard against potential interference, Pai has proposed that healthcare facilities be able to file a waiver request to extend WMTS protection zones to up to three times their current size. These zones will remain in effect until the FCC can determine the merits of the requests.

The medical device community also has expresses concerns. In comments submitted in March, GE Healthcare, which manufactures patient monitoring devices, said that the proposed separation distance requirements weren’t sufficient to protect WMTS. The company also urged the FCC to require unlicensed devicemakers to comply with a comprehensive system of quality regulations throughout the product’s lifecycle.

Ahead of the FCC announcement, Sens. Tammy Baldwin (D-Wisc.), Amy Klobuchar (D-Minn.) and Debbie Stabenow (D-Mich.) wrote to FCC Chairman Tom Wheeler urging a three-month delay to consider technical rules for the use of Channel 37 by unlicensed TVWS devices.

“Wireless medical telemetry service systems for cardiac and fetal monitoring in hospitals have long used Channel 37 to operate without interference, which could severely impact patient health and safety,” the lawmakers said. “We strongly urge you to give medical technology stakeholders and the unlicensed community more time to work out a technical sharing agreement that will maintain the safe use of all devices in Channel 37.”

The FCC decided against this request.

The American Hospital Association has come out against the decision, saying that if the rules aren’t changed, patient safety could be compromised. “We will continue to work with Congress, the FCC and device developers to seek a remedy that puts patients first,” AHA Executive Vice President Rick Pollack says.

To see the FCC report and order, visit www.fdanews.com/081715-fcc-WMTS.pdf.
— Elizabeth Hollis

Regulatory Affairs

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing